Startseite A clinical evaluation of controlled-release dinoprostone for cervical ripening – a review of current evidence in hospital and outpatient settings
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

A clinical evaluation of controlled-release dinoprostone for cervical ripening – a review of current evidence in hospital and outpatient settings

  • Werner Rath
Veröffentlicht/Copyright: 1. Dezember 2005
Journal of Perinatal Medicine
Aus der Zeitschrift Band 33 Heft 6

Abstract

Labor induction is used in approximately 20% of pregnancies in Europe and North America. Prostaglandins and prostaglandin analogs are favored when women undergoing labor induction have an unripe cervix. Controlled-release dinoprostone, delivered over 24 h from a vaginal insert, results in cervical ripening within 12 h in most women. It is marginally more effective than immediate release formulations and has similar efficacy to misoprostol, a prostaglandin E1 analog used off-label for this indication. The controlled-release preparation offers many advantages compared with an immediate-release formulation: a single application is sufficient; it is less invasive; it is easily administered and removed, allowing greater dose control. The most significant adverse effect, uterine hyperstimulation, with and without an effect on fetal heart rate, occurs in 5–15% of patients, which is comparable with other formulations or misoprostol. The insert can be removed easily on the first sign of uterine hyperstimulation, or as soon as labor starts. The efficacy and safety of controlled-release dinoprostone are comparable whether it is used in the outpatient or the inpatient setting. For low-risk women, outpatient use may be a highly attractive option, potentially reducing hospital costs, and improving patient convenience. The ease of use of controlled-release dinoprostone and women's satisfaction emphasize its benefits over many other agents used to ripen the cervix.

:

Corresponding author: Werner Rath, MD Department Obstetrics and Gynecology University of Aachen Pauwelsstraße 30 D-52074 Aachen, Germany

References

1 Anon: Induction of labor [ACOG technical bulletin]. Int J Gynaecol Obstet53 (1996) 65Suche in Google Scholar

2 American College of Obstetricians Gynecologists: ACOG technical bulletin. Induction of labor. Int J Gynaecol Obstet53 (1996) 65Suche in Google Scholar

3 American College of Obstetricians and Gynaecologists: Induction of labor. Practice bulletin no. 10. Washington, D.C.: ACOG, 1999Suche in Google Scholar

4 Biem SRD, RW Turnell, O Olatunbosun, M Tauh, HJ Biem: A randomized controlled trial of outpatient vs. inpatient labor induction with vaginal controlled-release prostaglandin-E2: effectiveness and satisfaction. J Obstet Gynaecol Can25 (2003) 23Suche in Google Scholar

5 Bishop EH: Pelvic scoring for elective induction. Obstet Gynecol24 (1964) 266Suche in Google Scholar

6 Blair FC, SA Tassone, CR Pearman, MB St Cyr, WF Rayburn: Inducing labor with a sustained-release PGE2 vaginal insert. Experience at a community hospital. J Reprod Med43 (1998) 408Suche in Google Scholar

7 Brest N, T Marlino, A Gerson: Outpatient cervical ripening with a dinoprostone vaginal insert. Today's Therapeutic Trends (In Press)Suche in Google Scholar

8 Calder AA, MP Embrey, K Hillier: Extra-amniotic prostaglandin E2 for the induction of labor at term. J Obstet Gynaecol Br Commonw81 (1974) 39Suche in Google Scholar

9 Calder AA: The management of the unripe cervix. In: Keirse MJNC, ABM Anderson, J Bennebroek Gravenhorst: Human Parturition. Leiden University Press, The Hague 197910.1007/978-94-009-9586-4_13Suche in Google Scholar

10 Chyu JK, HT Strassner: Prostaglandin E2 for cervical ripening: a randomized comparison of Cervidil vs. Prepidil. Am J Obstet Gynecol177 (1997) 606Suche in Google Scholar

11 Crane JM, KA Bennett: A meta-analysis of controlled-release prostaglandin for cervical ripening and labor induction. J Soc Obstet Gynaecol Canada22 (2000) 692Suche in Google Scholar

12 Crowley P: Interventions for preventing or improving the outcome of delivery at or beyond term (Cochrane Review). The Cochrane Library (2004) 1Suche in Google Scholar

13 D'Aniello G, C Bocchi, P Florio, E Ignacchiti, CG Guidoni, G Centini, et al.: Cervical ripening and induction of labor by prostaglandin E2: a comparison between intracervical gel and vaginal pessary. J Matern Fetal Med14 (2003) 158Suche in Google Scholar

14 Edwards RK, DS Richards: Preinduction cervical assessment. Clin Obstet Gynecol43 (2000) 440Suche in Google Scholar

15 Garry D, R Figuerosa, RB Kalish, CJ Catalano, D Maulik: Randomized controlled trial of vaginal misoprostol vs. dinoprostone vaginal insert for labor induction. J Matern Fetal Neonat Med13 (2003) 254Suche in Google Scholar

16 Goharkhay N, FZ Stanczyk, E Gentzschein, DA Wing: Plasma prostaglandin E2 metabolite levels during labor induction with a sustained-release prostaglandin E2 vaginal insert. J Soc Gynecol Investig7 (2000) 338Suche in Google Scholar

17 Hilder L, K Costeloe, B Thilaganathan: Prolonged pregnancy: evaluating gestation-specific risks of fetal and infant mortality. Br J Obstet Gynaecol105 (1998) 169Suche in Google Scholar

18 Hofmeyr GJ, Z Alfirevic, J Kavanagh, J Thomas, P Brocklehurst, JP Neilson: Methods for cervical ripening and labor induction in late pregnancy: generic protocol. Cochrane Database Syst Rev 200010.1002/14651858.CD002074Suche in Google Scholar

19 Hughes EG, AJ Kelly, J Kavanagh: Dinoprostone vaginal insert for cervical ripening and labor induction: a meta-analysis. Obstet Gynecol97 (2001) 847Suche in Google Scholar

20 Keirse MJNC, ACA van Oppen: Preparing the cervix for induction of labor. In: Chalmers I, M Enkin, MJNC Keirse: Effective care in pregnancy and childbirth. Oxford University Press, Oxford 1989Suche in Google Scholar

21 Keirse MJ: Prostaglandins in preinduction cervical ripening. Meta-analysis of worldwide clinical experience. J Reprod Med38 (1993) 89Suche in Google Scholar

22 Kelly AJ, Z Alfirevic, GJ Hofmeyr, J Kavanagh, JP Neilson, J Thomas: Induction of labor in specific clinical situations: generic protocol. Cochrane Database Syst Rev 200110.1002/14651858.CD003398Suche in Google Scholar

23 Kelly AJ, J Kavanagh, J Thomas: Vaginal prostaglandin (PGE2 and PGEF2a) for induction of labor at term. Cochrane Database Syst Rev 2003, 410.1002/14651858.CD003101Suche in Google Scholar

24 Khoury AN, QP Zhou, DM Gorenberg, BM Nies, GE Manley, FE Mecklenburg: A comparison of intermittent vaginal administration of two different doses of misoprostol suppositories with continuous dinoprostone for cervical ripening and labor induction. J Matern Fetal Med10 (2001) 186Suche in Google Scholar

25 Kozak LJ, JD Weeks: US trends in obstetric procedures, 1999–2000. Birth29 (2002) 157Suche in Google Scholar

26 Ludmir J, HM Sehdev: Anatomy and physiology of the uterine cervix. Clin Obstet Gynecol43 (2000) 433Suche in Google Scholar

27 Lyndrup J: Prostaglandins and induction of labor. Eur J Obstet Gynecol Reprod Biol64 (1996) 110.1016/0301-2115(95)02266-XSuche in Google Scholar

28 Lyrenas S, C Ingegerd, U Ulmsten: In vivo controlled release of PGE2 from a vaginal insert (0.8 mm, 10 mg) during induction of labor. Br J Obstet Gynaecol108 (2001) 169Suche in Google Scholar

29 Miller AM, WF Rayburn, CV Smith: Patterns of uterine activity after intravaginal prostaglandin E2 during preinduction cervical ripening. Am J Obstet Gynecol165 (1991) 1006Suche in Google Scholar

30 National Institute for Clinical Excellence, and the Royal College of Obstetricians and Gynaecologists: Induction of labor: Evidence-based clinical guideline. 2001Suche in Google Scholar

31 Ottinger WS, MK Menard, BC Brost: A randomized clinical trial of prostaglandin E2 intracervical gel and a slow release vaginal pessary for preinduction cervical ripening. Am J Obstet Gynecol179 (1998) 349Suche in Google Scholar

32 Perry MY, WL Leaphart. Randomized trial of intracervical vs. posterior fornix dinoprostone for induction of labor. Obstet Gynecol103 (2004) 13Suche in Google Scholar

33 Rath W, C Bartz, M Winkler: Geburtseinleitung bei unreifer Zervix mit dem PGE2-Vaginalinsert Propess®—ergebnisse einer prospectiven randomisierten Multizenterstudie im Vergleich mit der intrazervikalen Applikation von Prostaglandin-E2-Gel (Prepidil®). Frauenartz43 (2002) 1173Suche in Google Scholar

34 Rayburn WF, RJ Wapner, VA Barss, E Spitzberg, RD Molina, N Mandsager, et al.: An intravaginal controlled-release prostaglandin E2 pessary for cervical ripening and initiation of labor at term. Obstet Gynecol79 (1992) 374Suche in Google Scholar

35 Rayburn WF: Clinical experience with a controlled-release, prostaglandin E2 intravaginal insert in the USA. Br J Obstet Gynaecol104 (Suppl 15) (1997) 8Suche in Google Scholar

36 Sanchez-Ramos L, DE Peterson, J Delke, FL Gaudier, AM Kaunitz: Labor induction with prostaglandin E1 misoprostol compared with dinoprostone vaginal insert: A randomized trial. Obstet Gynecol91 (1998) 401Suche in Google Scholar

37 Sennik BK: Outpatient use of a sustained-release PGE2 vaginal insert – a retrospective study. Today's Therapeutic Trends19 (2001) 77Suche in Google Scholar

38 Simpson ML, O Von Lipinski, MG Radmanovic, NL Mitenko: Timed-release dinoprostone vaginal inserts in an outpatient and inpatient setting. Poster presented at ACOG Meeting, September 2004Suche in Google Scholar

39 Smith CV, WF Rayburn, AM Miller: Intravaginal prostaglandin E2 for cervical ripening and initiation of labor. Comparison of a multidose gel and single, controlled-release pessary. J Reprod Med39 (1994) 381Suche in Google Scholar

40 Taylor DR, AS Doughty, H Kaufman, L Yang, TA Iannucci: Uterine rupture with the use of PGE2 vaginal inserts for labor induction in women with previous caesarean sections. J Reprod Med47 (2002) 549Suche in Google Scholar

41 Taylor SJ, CL Armour: Consumer preference for dinoprostone vaginal gel using stated preference discrete choice modelling. Pharmaeconomics21 (2003) 721Suche in Google Scholar

42 Trofatter KF Jr: Endocervical prostaglandin E2 gel for preinduction cervical ripening. Clinical trials results. J Reprod Med38 (Suppl. 1) (1993) 78Suche in Google Scholar

43 Vollebregt A, DB van't Hof, N Exalto: Prepidil compared to Propess for cervical ripening. Eur J Obstet Gynecol Reprod Biol104 (2002) 116Suche in Google Scholar

44 Westgate J, JA Williams: Evaluation of a controlled release vaginal prostaglandin E2 pessary with a retrieval system for the induction of labor. J Obstet Gynaecol14 (1994) 146Suche in Google Scholar

45 Wieland D, F Friedman Jr: Comparing two dinoprostone agents for preinduction cervical ripening at term: A randomized trial. J Reprod Med44 (1999) 724Suche in Google Scholar

46 Wing DA, G Ortiz-Omphroy, RH Paul: A comparison of intermittent vaginal administration of misoprostol with continuous dinoprostone for cervical ripening and labor induction. Am J Obstet Gynecol177 (1997) 612Suche in Google Scholar

47 Witter FR, LE Rocco, TRB Johnson: A randomised trial of prostaglandin E2 in a controlled-release vaginal pessary for cervical ripening at term. Am J Obstet Gynecol166 (1992) 830Suche in Google Scholar

48 Witter FR, BM Mercer: Improved intravaginal controlled-release prostaglandin E2 insert for cervical ripening at term. The Prostaglandin E2 insert Study Group. J Matern Fetal Med5 (1996) 64Suche in Google Scholar

49 Wong SF, SK Hui, H Choi, LC Ho: Does sweeping of membranes beyond 40 weeks reduce the need for formal induction of labour? BJOG109 (2002) 632Suche in Google Scholar

Published Online: 2005-12-01
Published in Print: 2005-12-01

©2005 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Acknowledgement
  2. Index Volume 33 (2005)
  3. The role of Fas mediated apoptosis in preeclampsia
  4. New data about embryonic and fetal neurodevelopment and behavior obtained by 3D and 4D sonography
  5. A clinical evaluation of controlled-release dinoprostone for cervical ripening – a review of current evidence in hospital and outpatient settings
  6. The evidence linking maternal nutrition and prematurity
  7. Hydroxyprogesterone caproate and progesterone increase tumor necrosis factor-alpha production in lipopolysaccharide stimulated whole blood from non-pregnant women
  8. Routine cervical dilatation during elective cesarean section and its influence on maternal morbidity: a randomized controlled study
  9. Transient hypothyroxinemia of prematurity and histological chorioamnionitis
  10. Perinatal outcomes and the use of oral hypoglycemic agents
  11. Are amniotic fluid C-reactive protein and glucose levels, and white blood cell counts at the time of genetic amniocentesis related with preterm delivery?
  12. Combined sonographic and endoscopic umbilical cord occlusion in twin and triplet gestations
  13. Regional difference of endothelium-dependent contractility in human umbilical artery
  14. Isolated echogenic intracardiac foci in patients with low-risk triple screen results: assessing the risk of Trisomy 21
  15. Neonatal screening for congenital hypothyroidism in Hessen, Germany: efficiency of the screening program and school achievement of 129 children at an age of 8–12 years
  16. Utility of a Doppler-derived index combining systolic and diastolic performance (Tei index) for detecting hypoxic cardiac damage in newborns
  17. Breast-feeding in women with hypertensive disorders in pregnancy
  18. Intrauterine therapy for parvovirus B19 infected symptomatic fetus using B19 IgG-rich high titer gammaglobulin
  19. Failure of conservative management of placenta previa-percreta
  20. Congress Calendar
  21. Nomogram of the fetal gastric size development in normal pregnancy
Heruntergeladen am 12.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/JPM.2005.087/html?lang=de
Button zum nach oben scrollen